Cargando…

Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer

Detalles Bibliográficos
Autores principales: Curti, Brendan D, Akporiaye, Emmanuel, Sutcliffe, Kim, Bahjat, Keith S, Koguchi, Yoshinobu, Cramer, Julie, Urba, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645162/
http://dx.doi.org/10.1186/2051-1426-3-S2-P148
_version_ 1782400776206811136
author Curti, Brendan D
Akporiaye, Emmanuel
Sutcliffe, Kim
Bahjat, Keith S
Koguchi, Yoshinobu
Cramer, Julie
Urba, Walter
author_facet Curti, Brendan D
Akporiaye, Emmanuel
Sutcliffe, Kim
Bahjat, Keith S
Koguchi, Yoshinobu
Cramer, Julie
Urba, Walter
author_sort Curti, Brendan D
collection PubMed
description
format Online
Article
Text
id pubmed-4645162
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46451622015-11-20 Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer Curti, Brendan D Akporiaye, Emmanuel Sutcliffe, Kim Bahjat, Keith S Koguchi, Yoshinobu Cramer, Julie Urba, Walter J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645162/ http://dx.doi.org/10.1186/2051-1426-3-S2-P148 Text en Copyright © 2015 Curti et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Curti, Brendan D
Akporiaye, Emmanuel
Sutcliffe, Kim
Bahjat, Keith S
Koguchi, Yoshinobu
Cramer, Julie
Urba, Walter
Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
title Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
title_full Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
title_fullStr Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
title_full_unstemmed Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
title_short Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
title_sort phase i study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645162/
http://dx.doi.org/10.1186/2051-1426-3-S2-P148
work_keys_str_mv AT curtibrendand phaseistudyofalphatocopherlyoxyaceticacidinpatientswithadvancedcancer
AT akporiayeemmanuel phaseistudyofalphatocopherlyoxyaceticacidinpatientswithadvancedcancer
AT sutcliffekim phaseistudyofalphatocopherlyoxyaceticacidinpatientswithadvancedcancer
AT bahjatkeiths phaseistudyofalphatocopherlyoxyaceticacidinpatientswithadvancedcancer
AT koguchiyoshinobu phaseistudyofalphatocopherlyoxyaceticacidinpatientswithadvancedcancer
AT cramerjulie phaseistudyofalphatocopherlyoxyaceticacidinpatientswithadvancedcancer
AT urbawalter phaseistudyofalphatocopherlyoxyaceticacidinpatientswithadvancedcancer